An economical, effective and biocompatible gene therapy strategy promotes cardiac repair
Friday, July 6, 2012 - 22:00
in Health & Medicine
Medical researchers have established a novel hyperbranched poly(amidoamine) nanoparticle based hypoxia regulated vascular endothelial growth factor gene therapy strategy which is an excellent substitute for the current expensive and uncontrollable VEGF gene delivery system. This discovery provides an economical, feasible and biocompatible gene therapy strategy for cardiac repair.